02197 Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

0 Analyst Rating

Wall Street analysts forecast 02197 stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for 02197 is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

0 Buy

0 Hold

0 Sell

Current: 0.000

Low

Averages

High

Current: 0.000

Low

Averages

High

No data

Valuation Metrics

The current forward P/E ratio for CLOVER BIO-B (02197.HK) is 56.10, compared to its 5-year average forward P/E of 9.66. For a more detailed relative valuation and DCF analysis to assess CLOVER BIO-B 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

9.66

Current PE

56.10

Overvalued PE

29.48

Undervalued PE

-10.17

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

1.01

Current EV/EBITDA

15.65

Overvalued EV/EBITDA

6.37

Undervalued EV/EBITDA

-4.34

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

4.82

Current PS

3.90

Overvalued PS

16.58

Undervalued PS

-6.95

Financials

Annual

Quarterly

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

02197 News & Events

Events Timeline

No data

News

9.0

04:57 AMPRnewswire

PinnedClover Initiates Phase 2 Trial for RSV Vaccine, Enrolling 420 Participants

People Also Watch

Frequently Asked Questions

What is CLOVER BIO-B (02197) stock price today?

The current price of 02197 is 2.76 USD — it has decreased -4.83 % in the last trading day.

What is CLOVER BIO-B (02197)'s business?

What is the price predicton of 02197 Stock?

Wall Street analysts forecast 02197 stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for 02197 is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is CLOVER BIO-B (02197)'s revenue for the last quarter?

CLOVER BIO-B revenue for the last quarter amounts to NaN USD, decreased % YoY.

What is CLOVER BIO-B (02197)'s earnings per share (EPS) for the last quarter?

CLOVER BIO-B. EPS for the last quarter amounts to USD, decreased % YoY.

What changes have occurred in the market's expectations for CLOVER BIO-B (02197)'s fundamentals?

The market is revising No Change the revenue expectations for 02197 for , with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by %.

How many employees does CLOVER BIO-B (02197). have?

CLOVER BIO-B (02197) has 0 emplpoyees as of January 12 2026.

What is CLOVER BIO-B (02197) market cap?

Today 02197 has the market capitalization of 0.00 USD.